A detailed history of Sterling Capital Management LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Sterling Capital Management LLC holds 250 shares of DVAX stock, worth $2,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 246 1.63%
Holding current value
$2,765
Previous $2.44 Million 1.76%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$9.36 - $11.36 $37 - $45
4 Added 1.63%
250 $2.48 Million
Q2 2025

Aug 06, 2025

SELL
$9.4 - $12.87 $2,951 - $4,041
-314 Reduced 56.07%
246 $2.44 Million
Q1 2025

May 13, 2025

SELL
$12.39 - $14.4 $4,819 - $5,601
-389 Reduced 40.99%
560 $7.26 Million
Q4 2024

Feb 13, 2025

BUY
$10.28 - $13.66 $7,792 - $10,354
758 Added 396.86%
949 $12.1 Million
Q3 2024

Nov 12, 2024

BUY
$10.05 - $11.61 $1,919 - $2,217
191 New
191 $2.13 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.4B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.